The MEPs Against Cancer (MAC) Interest Group was founded in 2005 by a group of MEPs, and remains the only dedicated group for cancer policy at the European Parliament. MAC work together in order to improve cancer control and prevention in Europe, in the belief that European cooperation adds value to member state actions. 

In the 2014-19 parliamentary legislature, MAC had 40 members coming from different political groups and EU Member States. The President, Mr. Alojz Peterle (EPP, Slovenia), Vice-Presidents Ms. Nessa Childers (S&D, Ireland), Mr. Pavel Poc (S&D, Czech Republic), and Dr. Charles Tannock (ECR, United Kingdom), and other members were committed to taking action in the fight against cancer. 

Currently, the group is looking for new energetic members who wish to make beating cancer a #MissionPossible in the 2019-24 madate. 

STRATEGIC GOALS 2014-2019

I. Reducing cancer incidence by promoting prevention
II. Reducing mortality by ensuring equitable access to high quality treatment and care
III. Ensuring a good quality of life for cancer patients and survivors

 

Quote from the President 

“I think it is crucial for this term to provide more added value in the fight against cancer at the EU level, as well as better co-operation with stakeholders in the Member States. What is of the utmost importance is a concrete preventive policy in order to diminish the inflow of new cancer patients, which has been also the wish of the cancer patients in the EU.”

Alojz Peterle,
MAC President

SECRETARIAT

The Association of European Cancer Leagues (ECL) is honoured to have been appointed by MAC to provide secretarial support.  ECL is a Brussels‐based non‐profit organisation who represents national cancer societies across Europe. If you would like to become a member of MAC and make a difference in cancer control, receive more information about our initiatives or organise and event with MAC MEPs, please visit www.mepsagainstcancer.eu or contact us at MAC(at)europeancancerleagues.org.

 

MAC MEPs

Download MAC Leaflet
MAC Strategic Roadmap 2014-19